Paper published in a journal (Scientific congresses and symposiums)
Cost-effectiveness of sequential treatment with abaloparatide followed by alendronate vs. alendronate monotherapy for USA women at increased risk of fracture
Hiligsmann, M.; Williams, S.A.; Fitzpatrick, L.A.et al.
2019 • In Osteoporosis International, 30 (S2), p. 503-S504
Cost-effectiveness of sequential treatment with abaloparatide followed by alendronate vs. alendronate monotherapy for USA women at increased risk of fracture.pdf
Reginster, Jean-Yves ; Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Language :
English
Title :
Cost-effectiveness of sequential treatment with abaloparatide followed by alendronate vs. alendronate monotherapy for USA women at increased risk of fracture
Publication date :
July 2019
Event name :
World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases
